stockSPAREBANKEN SØR And MPC CONTAINER SHIP On The List Of Winners And Losers Of Wednesday's Euronext SessionViaNews Editorial Team (Europe)•Aug 28, 2024
stockCELYAD ONCOLOGY Stock Bullish Momentum With A 10.33% Jump On MondayViaNews Editorial Team (Europe)•Aug 26, 2024
stockEBUSCO HOLDING And REDITUS,SGPS On The List Of Winners And Losers Of Wednesday's Euronext SessionViaNews Editorial Team (Europe)•Aug 14, 2024
stockOCEANTEAM And SEQUANA MEDICAL On The List Of Winners And Losers Of Friday's Euronext SessionViaNews Editorial Team (Europe)•Aug 2, 2024
stockBASILIX CERT And SEQUANA MEDICAL On The List Of Winners And Losers Of Wednesday's Euronext SessionViaNews Editorial Team (Europe)•Jul 24, 2024
stockVIVORYON And GLINTT On The List Of Winners And Losers Of Thursday's Euronext SessionViaNews Editorial Team (Europe)•Jun 27, 2024
stockSAS AB And AKER HORIZONS On The List Of Winners And Losers Of Wednesday's Euronext SessionViaNews Editorial Team (Europe)•May 22, 2024
stockQUESTERRE ENERGY And SODITECH On The List Of Winners And Losers Of Friday's Euronext SessionViaNews Editorial Team (Europe)•Jan 26, 2024
stockBERGENBIO And NORTHERN DRILLING On The List Of Winners And Losers Of Monday's Euronext SessionViaNews Editorial Team (Europe)•Dec 4, 2023
stockCelyad Oncology Stocks Plunge 22%: What's Behind The Drop?ViaNews Editorial Team (Europe)•Nov 30, 2023
stockSAS AB And AVENIR TELECOM On The List Of Winners And Losers Of Friday's Euronext SessionViaNews Editorial Team (Europe)•Oct 27, 2023
stockCELYAD ONCOLOGY And AFFLUENT MEDICAL On The List Of Winners And Losers Of Friday's Euronext SessionViaNews Editorial Team (Europe)•Sep 15, 2023
stockCelyad Oncology Soars Over 25% In Final Hour Of Trading On FridayViaNews Editorial Team (Europe)•Sep 15, 2023
stockCELYAD Tumbles 12% As Trading Day Ends: Is It Time To Sell?ViaNews Editorial Team (Europe)•Sep 14, 2023
stockACANTHE DEV. And EBUSCO HOLDING On The List Of Winners And Losers Of Friday's Euronext SessionViaNews Editorial Team (Europe)•Sep 8, 2023
stockCELYAD ONCOLOGY Slumps 9% As Market Ends Session: Is Trouble Brewing?ViaNews Editorial Team (Europe)•Sep 4, 2023
stockCELYAD ONCOLOGY And ACCSYS On The List Of Winners And Losers Of Friday's Euronext SessionViaNews Editorial Team (Europe)•Sep 1, 2023
stockCELYAD ONCOLOGY Stock Was 30.85% Up Before The WeekendViaNews Editorial Team (Europe)•Sep 1, 2023